Kasabach-Merritt Phenomenon
- 1 July 2009
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Pediatric Hematology/Oncology
- Vol. 31 (7), 522-526
- https://doi.org/10.1097/mph.0b013e3181a71830
Abstract
Kasabach-Merritt phenomenon (KMP) is a rare thrombocytopenic consumption coagulopathy associated with an enlarging tufted angioma or kaposiform hemangioendothelioma. We report a case series of patients with KMP and discuss the treatment options and outcomes. Nine patients with a diagnosis of KMP were identified through retrospective chart review-6 had "definite KMP" and 3 had "less likely KMP." The hematologic features of KMP and those of chronic coagulopathy seen with other vascular malformations can be similar, which makes KMP difficult to distinguish.Keywords
This publication has 9 references indexed in Scilit:
- Early surgical intervention in a patient with Kasabach-Merritt phenomenonThe Journal of Pediatrics, 2001
- Kasabach–merritt syndrome: pathogenesis and managementBritish Journal of Haematology, 2001
- Toxicity profile of interferon alfa-2b in children: A prospective evaluationThe Journal of Pediatrics, 1999
- Thrombocytopenic Coagulopathy (Kasabach-Merritt Phenomenon) Is Associated with Kaposiform Hemangioendothelioma and Not with Common Infantile HemangiomaPlastic and Reconstructive Surgery, 1997
- Outcome of radiation therapy for patients with Kasabach-Merritt syndromeInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Successful Treatment of Infantile Hemangiomas with Interferon-α-2bJournal of Pediatric Hematology/Oncology, 1997
- High dose intravenous methylprednisolone for Kassabach-Merritt syndromeEuropean Journal of Pediatrics, 1989
- Corticosteroid Treatment of Cutaneous Hemangiomas : How Effective?Clinical Pediatrics, 1978
- CAPILLARY HEMANGIOMA WITH EXTENSIVE PURPURAAmerican Journal of Diseases of Children, 1940